$GCTKAug 28, 2026, 8:32 PMAI processed8-K/A
Glucotrack files 8‑K/A adding Lokahi financials and pro forma for reverse merger
AI Summary
GLUCOTRACK, INC. filed SEC Form 8-K/A. Glucotrack filed Amendment No. 1 to its Form 8‑K to furnish Lokahi Therapeutics Inc.'s audited (2024–2025) and unaudited (as of June 30, 2026 and six months ended June 30, 2026) financial statements and related notes in connection with the previously reported reverse merger. The amendment also includes Lokahi's MD&A, unaudited pro forma combined financial statements reflecting the merger and a consent of the independent registered public accounting firm, and states it does not amend other disclosures in the original report or reflect events after that filing.
Positives
- Filed Lokahi audited financial statements for 2024 and 2025 plus unaudited H1 2026 and related notes (provides required historical financials for the acquired business).
- Included unaudited pro forma combined financial statements showing the effects of the merger as of June 30, 2026 and pro forma statements for prior periods (gives a consolidated financial picture post-merger).
Negatives
No negative notes were stored with this alert.